NCT07028645

Uroflowmetry and Nocturnal Enuresis

Is Uroflowmetry Useful in Assessing Response to Pharmacological Treatment in Enuresis

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 100 (estimated)
• Sponsor: Furkan Adem Canbaz · Academic / Other
• Sex: All
• Age: 5 Years – 17 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate the uroflowmetry parameters of patients which were treated for enuresis.

Detailed description

A total of approximately 100 patients with enuresis will be evaluated retrospectively. Uroflowmetry parameters of these patients will be evaluated. For this purpose, patients will be divided to mainly three groups according to the treatment choices.

Conditions

• Enuresis, Nocturnal

Interventions

Type	Name	Description
DRUG	desmopressin melt form 120 μg	Desmopressin 120 mcg will be used frist-line drug in the treatment of enuresis.
DRUG	Desmopressin lyophilisate (Melt)	Desmopressin 240 mcg will be used for the patients who have not responsive to desmopressin 120 mcg.
DRUG	Propiverine tablet	Propiverine (a dose of 0.8 mg/ kg) will be used for the patients who have -response to treatment with desmopressin 240 mcg

Timeline

• Start date: 2022-08-20
• Primary completion: 2024-09-01
• Completion: 2025-12-30
• First posted: 2025-06-19
• Last updated: 2025-06-24

Locations

1 site across 1 country: Turkey (Türkiye)

Regulatory

• FDA-regulated drug study